We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Calliditas Therapeutics AB (CALTX) NPV

Sell:206.20 SEK Buy:206.40 SEK Change: No change
Market closed |  Prices as at close on 19 July 2024 | Switch to live prices |
Takeover

Calliditas Therapeutics AB NPV

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 13 Jun 2024)

The boards of Calliditas Therapeutics AB and Asahi Kasei Corporation recently announced the terms of a takeover. Under the terms of the takeover you have been offered SEK208.00 for each share held.

 

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

 

Sell shares in the offer – Act by noon on Tuesday 27 August 2024

 

Will I receive any cash proceeds in Swedish Krona?

 

No, cash from any successful tender will be converted to Pound Sterling by CREST, the UK settlement system, prior to receipt and credited to your account.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:206.20 SEK
Buy:206.40 SEK
Change: No change
Market closed |  Prices as at close on 19 July 2024 | Switch to live prices |
Takeover

Calliditas Therapeutics AB NPV

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 13 Jun 2024)

The boards of Calliditas Therapeutics AB and Asahi Kasei Corporation recently announced the terms of a takeover. Under the terms of the takeover you have been offered SEK208.00 for each share held.

 

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

 

Sell shares in the offer – Act by noon on Tuesday 27 August 2024

 

Will I receive any cash proceeds in Swedish Krona?

 

No, cash from any successful tender will be converted to Pound Sterling by CREST, the UK settlement system, prior to receipt and credited to your account.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:206.20 SEK
Buy:206.40 SEK
Change: No change
Market closed |  Prices as at close on 19 July 2024 | Switch to live prices |
Takeover

Calliditas Therapeutics AB NPV

Type:
Takeover
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 13 Jun 2024)

The boards of Calliditas Therapeutics AB and Asahi Kasei Corporation recently announced the terms of a takeover. Under the terms of the takeover you have been offered SEK208.00 for each share held.

 

If you don’t want to sell any shares, you don’t need to do anything. Depending on the level of acceptance the offeror may choose to delist or compulsorily acquire the remaining shares at a later date.

 

Sell shares in the offer – Act by noon on Tuesday 27 August 2024

 

Will I receive any cash proceeds in Swedish Krona?

 

No, cash from any successful tender will be converted to Pound Sterling by CREST, the UK settlement system, prior to receipt and credited to your account.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

HL comment

HL comment is not available for this stock.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.